Updated April 29 at 2:29pm
Biotechnology
53 results total, viewing 21 - 30
Life sciences company CytoSolv Inc. has been acquired by Semma Therapeutics of Cambridge, Mass., according to a Slater Technology Fund press release. more
Medical-device companies, under pressure from hospitals and health insurers to keep expenses down, are capitalizing on strong cash flows and the stumbling stock market to beef up cost-controlling technologies that may be critical to maintaining growth. more
A project about creating biodegradable plastics – also known as bioplastics – out of cornstarch, potatoes and milk has made a biotechnology class at East Greenwich High School a finalist in Samsung’s “Solve for Tomorrow” contest. more
I’m seeing lots of news reports about the end of the new Silicon Valley tech “bubble.” I put that word in quotes because the current situation doesn’t look much like the bubble of the late 1990s. But there still might soon be a broad drop in funding for startups, and a fall in the valuations of these companies. more
A biomedical engineering professor at the University of Rhode Island has received a $6 million National Science Foundation grant for research to show how the nervous system functions in health and disease. more
Twenty-six Real Jobs RI grant recipients were announced Monday by Gov. Gina M. Raimondo and the congressional delegation. more
Amgen Inc. won U.S. approval for its powerful cholesterol-lowering drug Repatha for certain patients, making it the second in a new class of treatments to come to market. more
Gov. Gina M. Raimondo and Commerce Secretary Stefan Pryor launched three new incentive programs on Wednesday in an effort to grow the state’s economy. more
Dr. Yow-Pin Lim, founder and CEO of ProThera Biologics in Providence, talks with Providence Business News about his company’s partnership with ProMetic Life Sciences Inc., its move last year to the Jewelry District, and how it is on track to start clinical trials of its lead therapeutic product next year. The company currently employs seven. more
When the University of Rhode Island’s Department of Cell and Microbiology saw an opportunity to help address the needs of Rhode Island’s biotech and pharmaceutical companies and satisfy student interest, it ran with it. more
« Prev | 1 | 2 | 3 | 4 | 5 | 6 Next »